India accounts for 57% of leprosy cases globally: Dr Lobo at book launch

Dr Lobo shared his thoughts on leprosy at the launch event of his book titled 'Dr S K Noordeen: Architect of the Global Leprosy Elimination Program'

Sasakawa-India Leprosy Foundation
L-R Mr Gaurab Sen, Mr Tarun Das, Dr Soumya Swaminathan, Dr Derek Lobo, Dr Vivek Lal, Team Leader, Global Leprosy Programme, WHO.
BS Web Team New Delhi
3 min read Last Updated : Feb 06 2023 | 7:54 PM IST
As the world marked Leprosy Day on January 30, industry veterans gathered at an event for the launch of the book: Dr S K Noordeen: Architect of the Global Leprosy Elimination Program. The book has been authored by Dr Derek Lobo, Member, Board of Trustees, Sasakawa India Leprosy Foundation (S-ILF). Dr Soumya Swaminathan, Former Chief Scientist, World Health Organisation (WHO) was the chief guest at the event. 

The event was hosted by Sasakawa-India Leprosy Foundation (S-ILF), which provided a platform to discuss the current state of the persons affected by leprosy around the world.

India accounts for 57 per cent of leprosy cases globally where 121 countries account for 40 per cent of cases. Prior to the Covid-19 pandemic, over 200,000 new cases were being reported annually. Leprosy is curable with multidrug therapy but left untreated can result in permanent disability. An estimated three to four million people are thought to be living with some form of disability as a result of leprosy.

Dr Lobo said, “India accounts 57 per cent of leprosy cases globally where 121 countries account for 40 per cent of cases. World Health Organisation (WHO) is working tremendously to eliminate leprosy, in fact, 31 countries have recorded zero leprosy cases, whereas 30 countries recorded fewer than 10 cases nationally. Only Brazil, India & Indonesia are such countries which have recorded more than 10,000 cases of leprosy.”

Sharing his thoughts on the book, Dr Derek Lobo said, "Dr S K Noordeen was a very humble person, with a constant focus towards eliminating leprosy. Over the years he worked tirelessly towards the cause and received numerous achievements but never thought of writing about it. After his demise, he decided to write the book on his story as a gesture towards him."

In a conversation with Mr Tarun Das, Chairman, S-ILF regarding the changing scenario in the world owing to the awareness around the disease, Dr. S Swaminathan said, "There was a quote and I would paraphrase it a little -Never doubt a small group which can change the world. I say it can be a single man who can do it all with sheer commitment, perseverance & dedication. WHO is grateful that Dr. Noordeen was there at the right time to formulate the plan to work towards eliminating leprosy. One needs to learn the characteristics of the disease to eliminate it. One of the challenges in elimination of the disease is that awareness goes down and along with the funding & research in domino effect. It is very difficult for the individual who goes through the infection, and it gets worse because of the stigma. Though we must accept the fact that leprosy is not infectious, there is no risk, people infected with leprosy can live a proactive life".

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :LeprosyBookhealthcare

Next Story